Current treatments and trials in malignant pleural mesothelioma
Author:
Affiliation:
1. Academic Respiratory Unit; Translation Health Science; Bristol Medical School; Bristol United Kingdom
2. North Bristol Lung Centre; North Bristol NHS Trust; Bristol United Kingdom
Publisher
Wiley
Subject
Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/crj.12938/fullpdf
Reference43 articles.
1. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003
2. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European organisation for research and treatment of cancer lung cancer group and the national cancer institute of Canada;Meerbeeck;J Clin Oncol,2005
3. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial;Alley;Lancet Oncol,2017
4. Phase 1 dose-escalation study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1-deficient thoracic cancers;Beddowes;J Clin Oncol,2017
5. Nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso Trial;Grosso;J Clin Oncol,2017
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Success of Checkpoint Blockade Paves the Way for Novel Immune Therapy in Malignant Pleural Mesothelioma;Cancers;2023-05-27
2. BCG: Past, Present and Future Direction;Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges;2023
3. A Case of Pneumonia Masking Pleural Malignancy;OncoTargets and Therapy;2022-07
4. Patients' and informal carers’ experience of living with mesothelioma: A systematic rapid review and synthesis of the literature;European Journal of Oncology Nursing;2022-06
5. Gender and the experiences of living with mesothelioma: A thematic analysis;European Journal of Oncology Nursing;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3